Outcome of acute stroke treatment with intravenous thrombolytic drug in Singburi Hospital
Keywords:
Acute ischemic stroke, intravenous thrombolysis, good outcomeAbstract
Objectives: To study clinical outcome after treated with intravenous thrombolytic drug in acute ischemic stroke in Singburi Hospital .The secondary objective was to study factor affecting good outcome patients. A retrospective study of data from medical records of patients diagnosed with acute stroke treated with intravenous thrombolytic drugs admitted to Singburi Hospital. During the period from 1 January 2016–30 April 2020, the basic information of the underlying disease is collected. 98 patients who received intravenous thrombosis medications for up to 3 months analyzed the data using descriptive statistics, average, percentage, Mann whitney U Test and logistical regression analysis. Results: Seventy-four patients, age 41-83 years old, an average age 64.0±10.9 years old, good outcome after treated with intravenous thrombolytic drugs was 49 patients (66.2%), An average onset to door time 106.1±49.9 minutes. An average door to needle time 64.4±28.5 minutes. An average onset to needle time 171.0±52.2 minutes. An median NIHSS 8. From the study, factors associated with good outcome were Triglyceride greater than 150 mg/dl and NIHSS at ER <10. Conclusions: Almost outcome of treatement with intravenous thrombolytic drug in acute ischemic stroke is good outcome about 66.2 percent. Factors associated with good outcome were triglyceride greater than 150 mg/dl and NIHSS at ER <10.
Downloads
References
Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120(3):439-48.
กลุ่มข้อมูลข่าวสารสุขภาพ, กองยุทธศาสตร์และแผนงานสำนักงานปลัดกระทรวงสาธารณสุข, สถิติสาธารณสุข พ.ศ. 2561:77-78.
Truelsen T, Begg S, Mathers C. The global burden of cerebrovascularDisease [Internet]. 2000 [cited 2017 Jun 15]. 1-56. Available from: http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.pdf.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–7.
Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945–8.
Jauch EC, Saver JL, Adams HP, et al. guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–e99.
Powers WJ,Ackerson Teri,Bambakidis NC,et al.2019 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;49:e344–e418.
Lees KR, Bluhmki E, Kummer R von, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooledanalysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703.
Dharmasaroja PA, Dharmasaroja P, Muengtaweepongsa S. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis. J Neurol Sci 2011;300:74-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Singburi Hospital

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The published articles are copyrighted by Singburi Hospital.
The statements appearing in each article in this academic journal are the personal opinions of each author and are not related in any way to Singburi Hospital or other hospital personnel. Each author is solely responsible for all contents of their article. If there are any errors, each author alone will be responsible for their own article.
